We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Bio-Rad Introduces Microsatellite Instability Assay for Colorectal Cancer

Bio-Rad Introduces Microsatellite Instability Assay for Colorectal Cancer content piece image
Droplet Digital PCR (ddPCR) Assay
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute
Bio-Rad’s Droplet Digital PCR (ddPCR) Microsatellite Instability (MSI) RUO Assay is available for early access customers. The ddPCR MSI assay can be completed in one day on a ddPCR-based platform to quantify the level of MSI present in colorectal tumors. Using either a blood or FFPE sample, the assay quantitatively identifies mutations in five loci that lead to identification of MSI status. Colorectal tumors that test positive for MSI-high are candidates for treatment with immune-checkpoint inhibitors. Bio-Rad’s assay is simple, highly sensitive and provides a standardized output that does not require a pathologist’s interpretation. The test can use patient blood samples in the absence of tumor tissue and does not require matched normal tissue or normal blood samples. Visit our website for more information.

For research use only. Not for use in diagnostic procedures.